Mode
Text Size
Log in / Sign up

Do cohort studies show clinical outcomes for pediatric acute respiratory infections?

high confidence  ·  Last reviewed May 27, 2026

Cohort studies are a cornerstone of research on pediatric acute respiratory infections (ARIs). They follow groups of children over time to track infections, symptoms, and outcomes. A systematic review of the 50 most-cited articles on pediatric respiratory infections found that cohort studies made up 66% of these influential papers 1. These studies provide real-world evidence on which pathogens are circulating, how often co-infections occur, and what clinical outcomes children experience, such as hospitalization, need for oxygen, or intensive care.

What the research says

Multiple recent cohort studies have detailed the clinical outcomes of pediatric ARIs. A large retrospective cohort study in Xiantao, China, analyzed 4,330 hospitalized children using targeted next-generation sequencing and found that 99.3% had a detectable pathogen, with 88.7% having co-infections involving two or more pathogens 6. The most common clinical diagnoses were pneumonia (57.8%) and acute upper respiratory infections (24.1%) 6. Another longitudinal cohort study in Shenzhen, China, followed over 74,000 hospitalized children from 2019 to 2024 and found that human rhinovirus (HRV) was detected in 25.13% of cases, with HRV-A being the most common subtype 7. This study also showed how the COVID-19 pandemic and non-pharmaceutical interventions altered HRV circulation patterns 7.

A retrospective cohort study in Ankara, Turkey, of 1,465 hospitalized children found that influenza virus was the most common pathogen (30.1%), followed by human bocavirus (28.3%) and respiratory syncytial virus (18.4%) 8. Over half of infections occurred in winter, and clinical outcomes varied by virus: fever was most common with influenza, while cough and hypoxia were more frequent with RSV and hBoV 8. The study also reported that 32.9% of children had chronic health conditions, which can worsen outcomes 8.

Beyond pathogen-specific studies, cohort research has also evaluated healthcare delivery models. A retrospective cohort study of a Hospital at Home (HAH) service in England, which included patients with acute respiratory infections, found that HAH reduced length of stay by about 3 days and lowered 30-day readmission rates compared to inpatient care 5. This demonstrates how cohort studies can assess not just disease outcomes but also the effectiveness of different care settings.

What to ask your doctor

  • What are the most common respiratory viruses or bacteria circulating in our area this season?
  • If my child has a co-infection (more than one pathogen), does that change the treatment or outlook?
  • Are there any local cohort studies that show which children are at higher risk for severe ARI outcomes?
  • Would my child be a candidate for a Hospital at Home program if they develop a respiratory infection?
  • How do chronic health conditions affect the risk of severe ARI in children?

This question is drawn from common patient questions about Pulmonology & Critical Care and answered using cited medical research. We do not provide individualized advice.